Aged Tendon Stem/Progenitor Cells Are Less Competent to Form 3D Tendon Organoids Due to Cell Autonomous and Matrix Production Deficits by Yan, Zexing et al.
fbioe-08-00406 May 1, 2020 Time: 12:38 # 1
ORIGINAL RESEARCH
published: 05 May 2020
doi: 10.3389/fbioe.2020.00406
Edited by:
Dimitrios I. Zeugolis,
National University of Ireland Galway,
Ireland
Reviewed by:
Andreas Traweger,
Paracelsus Medical University, Austria
Zi Yin,
Zhejiang University, China
*Correspondence:
Denitsa Docheva
denitsa.docheva@ukr.de
Specialty section:
This article was submitted to
Tissue Engineering and Regenerative
Medicine,
a section of the journal
Frontiers in Bioengineering and
Biotechnology
Received: 10 December 2019
Accepted: 09 April 2020
Published: 05 May 2020
Citation:
Yan Z, Yin H, Brochhausen C,
Pfeifer CG, Alt V and Docheva D
(2020) Aged Tendon Stem/Progenitor
Cells Are Less Competent to Form 3D
Tendon Organoids Due to Cell
Autonomous and Matrix Production
Deficits.
Front. Bioeng. Biotechnol. 8:406.
doi: 10.3389/fbioe.2020.00406
Aged Tendon Stem/Progenitor Cells
Are Less Competent to Form 3D
Tendon Organoids Due to Cell
Autonomous and Matrix Production
Deficits
Zexing Yan1, Heyong Yin1, Christoph Brochhausen2, Christian G. Pfeifer1, Volker Alt1 and
Denitsa Docheva1,3*
1 Experimental Trauma Surgery, Department of Trauma Surgery, University Regensburg Medical Centre, Regensburg,
Germany, 2 Institute of Pathology, University of Regensburg, Regensburg, Germany, 3 Department of Medical Biology,
Medical University of Plovdiv, Plovdiv, Bulgaria
Tendons are dense connective tissues, which are critical for the integrity and function
of our musculoskeletal system. During tendon aging and degeneration, tendon
stem/progenitor cells (TSPCs) experience profound phenotypic changes with declined
cellular functions that can be linked to the known increase in complications during
tendon healing process in elderly patients. Tissue engineering is a promising approach
for achieving a complete recovery of injured tendons. However, use of autologous cells
from aged individuals would require restoring the cellular fitness prior to implantation.
In this study, we applied an established cell sheet model for in vitro tenogenesis
and compared the sheet formation of TSPC derived from young/healthy (Y-TSPCs)
versus aged/degenerative (A-TSPCs) human Achilles tendon biopsies with the purpose
to unravel differences in their potential to form self-assembled three-dimensional
(3D) tendon organoids. Using our three-step protocol, 4 donors of Y-TSPCs and
9 donors of A-TSPCs were subjected to cell sheet formation and maturation in a
period of 5 weeks. The sheets were then cross evaluated by weight and diameter
measurements; quantification of cell density, proliferation, senescence and apoptosis;
histomorphometry; gene expression of 48 target genes; and collagen type I protein
production. The results revealed very obvious and significant phenotype in A-TSPC
sheets characterized by being fragile and thin with poor tissue morphology, and
significantly lower cell density and proliferation, but significantly higher levels of the
senescence-related gene markers and apoptotic cells. Quantitative gene expression
analyses at the mRNA and protein levels, also demonstrated abnormal molecular circuits
in the A-TSPC sheets. Taken together, we report for the first time that A-TSPCs exhibit
profound deficits in forming 3D tendon tissue organoids, thus making the cell sheet
model suitable to investigate the molecular mechanisms involved in tendon aging and
degeneration, as well as examining novel pharmacologic strategies for rejuvenation of
aged cells.
Keywords: tendon age-related degeneration, tendon stem/progenitor cells, tenogenesis, 3D cell sheet model,
tendon regeneration
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INTRODUCTION
Tendons are dense connective tissues, which are critical for the
integrity and function of our musculoskeletal system (Schiele
et al., 2013; Docheva et al., 2015; Costa-Almeida et al., 2019).
Tendons are hierarchically organized and have an extracellular
matrix (ECM) consisting mainly of collagen type I and a smaller
portion of other collagens and proteoglycans (Yan et al., 2018).
After injury, tendons need a long period for rehabilitation,
especially in aged patients, accompanied with higher failure
risk and unsatisfactory repair outcomes (Hirzinger et al., 2014).
Tissue aging involves many intrinsic and extrinsic processes and
it is frequently linked with tissue degeneration, tendon rupture
incidence as well as reduced healing capacity (Gumucio et al.,
2014; Schneider et al., 2018; Steinmann et al., 2020). In general,
aging is reflected by a decline in organ and tissue homeostasis
(de Lucas et al., 2018). Many studies on age-related diseases
have revealed that a diminished stem cell pool is responsible for
adult tissue degeneration (Zhang et al., 2018). However, the exact
molecular mechanism behind tendon aging and degeneration
remain by large unclear.
By carrying out a direct comparison between TSPCs derived
from young/healthy (Y-TSPC) and aged/degenerative (A-TSPC)
Achilles tendons, we have reported that A-TSPCs exhibit in two
dimensional (2D) culture profound phenotypic changes with
a decline in multiple cellular functions (Kohler et al., 2013).
Moreover, microarray analysis showed a distinct transciptomal
shift mRNA in A-TSPCs, namely, genes related to cell-cell
and cell-matrix contacts, cytoskeleton and cell motility were
significantly dysregulated (Kohler et al., 2013). F-actin imaging
as well as quantitative kinetic analysis of cytoskeleton turnover,
demonstrated that A-TSPCs have accumulation of robust
actin stress fiber with slow turnover that correlated with the
significantly reduced migratory and in vitro would healing
potential of these cells (Kohler et al., 2013).
Self-assembled three-dimensional (3D) organoids, whereby
cells form connections naturally between each other and to the
deposited ECM, are considered as a promising culture models to
investigate tissue formation in vitro. One widely used scaffold-
free approach is the cell pellet model for in vitro chondrogenesis.
For tenogenesis, more a tube-like cell sheet, composed of a
multi-layered cellular architecture and ECM-rich patches, can be
fabricated in vitro (Ni et al., 2013). These organoids maintain
natural microenvironment and own autocrine and paracrine
signaling pathways. Our recent results on 3D cell sheets formed
by mesenchymal stem cells and TSPCs provided evidences for the
Abbreviations: ACAN, aggrecan; ACTA2, alpha-actin 2; ADSC, adipose-derived
stem cell; AR, aspect ratio; A-TSPC, aged tendon stem/progenitor cell; BMSC,
bone mesenchymal stem cell; BSA, bovine serum albumin; CDKN2a, cyclin-
dependent kinase Inhibitor 2a; COL, collagen; COMP, cartilage oligomeric matrix
protein; DCN, decorin; DES, desmin; ELISA, enzyme-linked immunosorbent
assay; ECM, extracellular matrix; FMOD, fibromodulin; FN, fibronectin; LPL,
lipopretionlipase; NAR, nuclear aspect ratio; OSX, osterix; PBS, phosphate
buffered saline; PLOD, procollagen-Lysine,2-Oxoglutarate 5-Dioxygenase 1; RT,
room temperature; TEM, transmission electron microscopy; TGFB1, transforming
growth factor beta 1; THBS, thrombospondin; TNC, tenascin C; TUNEL, terminal
deoxynucleotidyl transferase dUTP nick end labeling; Y-TSPC, young tendon
stem/progenitor cell.
suitability of this model to study in vitro tenogenic differentiation
(Hsieh et al., 2018).
Thus, in this study we hypothesized that A-TSPCs will
exhibit significant differences to Y-TSPCs in their potential
to form 3D tendon organoids and our aims were first, to
characterize the quality of the tendon sheets and second to outline
dominant cellular and molecular traits underlying the expected
A-TSPC phenotype.
MATERIALS AND METHODS
Cell Culture
Primary Y-TSPCs (n = 4) and A-TSPCs (n = 9) were collected
from human non-injured Achilles tendon biopsies with an
average age of 28 ± 5 years and 61 ± 13 years, respectively,
and extensively validated and characterized in 2D culture (Kohler
et al., 2013; Popov et al., 2015) (Ethical Grant No. 166-08
of the Medical Faculty of the Ludwig-Maximilians-University,
Munich). Details on donor cohort demographics, clinical
indications, histological examination, inclusion and exclusion
criteria are published in the Supplementary Information
of Kohler et al. (2013). In short, The Y-TSPC cohort
was limited to only n = 4 due to the rarity of such
clinical samples. The donors for the A-TSPC cohort were
validated for degenerative status by histological examination.
For extraction and purification of the cells, the tendon tissue
was minced into small pieces, digested with 0.15% collagenase
II (Worthington, Lakewood, NJ, United States) enzymatically
in culture medium at 37◦C overnight, then filtered with
sterile nylon mesh (100 µm pore size), and centrifuged at
500 g for 10 min. No enrichment step was implemented.
Afterward, the pelleted cells were resuspended and expanded
in DMEM/Ham’s F-12 medium with glutamine (365.3 mg/L),
1 × MEM amino acids, 10% FBS and 1% L-ascorbic acid-2-
phosphate. Stem/progenitor character of the cells was verified
in Kohler et al. (2013) by FACS and immunohistochemistry
for MSC-related markers positive markers CD44, CD73, CD90,
CD105, CD146 (pericyte marker), Musashi-1 and STRO-1
as well as negative markers CD19, CD34, CD45, HLA-DR)
revealing a very homogeneous populations. Tendon-related
genes such as the transcription factors Scleraxis, Eya1, and
Six1, the tendon marker gene tenomodulin and several ECM
proteins abundant in tendon (collagen types I and III, COMP,
decorin, and tenascin C) were validated (Kohler et al., 2013).
Self-renewal and tri-lineage differentiation assays were also
carried (Kohler et al., 2013). For passaging, 60% confluent cells
were detached by trypsin. Cells were used in the study at
passage 2–6.
Cell Sheet Formation
The cell sheet protocol, depicted in Figure 1A, comprises of
a three-step procedure: expansion, stimulation and maturation
(Hsieh et al., 2018). The three-step procedure is required for
the self-assembly process of the cell sheet with (1) expansion –
formation of confluent cell layer; (2) stimulation - for apical
deposition of ECM and enrichment cell-ECM interactions
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FIGURE 1 | Cell sheet procedure and gross morphological data. (A) Cartoon depicting the 3-step protocol for cell sheet formation. (B) Representative macroscopy
images Y-TSPC and A-TSPC sheets at day 14. (C) Success rate of all donors (upper panel) success rate of each individual donor (lower panel). (D) Comparison of
TSPC sheet wet weight at day 1 and 14. (E) Comparison of TSPC sheet diameter at day 1 and 14. Y-TSPC n = 4; A-TSPC n = 9; *p < 0.05, **p < 0.01, and
***p < 0.001.
(glucose for energy supply, and ascorbic acid to serve as anti-
oxidant and co-factor for collagen synthesis); and (3) maturation
- by tendon specific ECM production and organization in the
3D space (TGF- β3 mediated signaling is critical for tenogenesis
(Havis et al., 2014, 2016). In the expansion step, both cell
types (8 × 103 cells/cm2) were cultured in 10 cm2 cell culture
dishes (Falcon, New York, United States) until reaching full
confluence in the basic medium. In the stimulation step, cells
were supplemented with high glucose DMEM containing 10%
FBS and 50 µg/mL ascorbic acid for 14 (Y-TSPCs) or 16.5 days
(A-TSPCs). Afterwards, the continuous cell monolayers were
detached manually with a cell scraper, rolled into a 3D tube-like
cell sheet, stretched 10% manually and fixed with small pins in
non-adhesive culture dish (Corning, New York, United States).
In the last maturation step, all formed cell sheets were cultured
for 14 days in maturation media containing high glucose DMEM
with 10 ng/ml TGF-β3 and 50 µg/mL ascorbic acid.
Cell Sheet Wet Weight and Diameter
Analysis
Cell sheets wet weight and diameter were measured at day 1
and day 14 of the maturation step. For diameter evaluation,
following algorithm was applied: (1) 5–8 sheets/donor were
imaged; (2) 6 images/sheet were implemented; 5 diameters/image
were measured manually and the mean was calculated; (3) the
diameter of each sheet was analyzed as the mean from 6 images;
(4) the diameter for each donor was expressed as mean diameter
of 5–8 sheets. 4 Y-TSPC cell sheet and 9 A-TSPC cell sheet donors
were applied. The quantitative data was processed with GraphPad
Prism v.5 software (GraphPad software, CA, United States).
Cell Sheet Fixation and Cryo Cutting
Y-TSPC (n = 4 donors) and A-TSPC (n = 6 donors) cell
sheets (2 sheets/donor) were fixed with 4% paraformaldehyde,
cryoprotected with 10, 20, 30% sucrose/phosphate-buffered
saline (PBS) gradient (Sigma-Aldrich Corporation, St Louis,
United States) and embedded in Tissue-Tek (Sakura Finetek,
Alphen aan den Rijn, Netherlands). Cryosections (10 µm
thick) were collected with cryotome (Leica, Wetzlar, Germany),
and stored until use at −20◦C. Prior to staining, sections
were equilibrated at room temperature and rehydrated
with PBS for 5 min.
H&E (Hematoxylin and Eosin) Staining
and Nuclear Angle Deviation Analysis
4 Y-TSPC (n = 4 donors) and 6 A-TSPC (n = 6 donors), the
sheets (1 sheet/donor) were placed in Hematoxylin solution
for 3 min, rinsed with 0.1% HCl in PBS for dedifferentiation,
washed in tap water for 5 min, immersed in Eosin solution for
3 min (both from Carl Roth, Karlsruhe, Baden-Württemberg,
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Germany), rinsed with distilled water for 30 s and covered with
Depex (Serva, Heidelberg, Germany). H&E staining images were
made with Nikon digital sight DS-U camera mounted at Nikon
eclipse TE2000-U microscope (Nikon, Tokyo, Japan) and used
for analysis of nuclear angular deviation. Since healthy resident
cells in tendon tissue are well aligned to the tensile axis (muscle
to bone), this parameter is useful to assess the quality of the
3D sheet organization, and the lesser the deviation the better
the alignment. The following algorithm was implemented: (1)
9 images at x20 magnification were taken randomly from each
cell sheet; (2) 9 randomly chosen nuclei per image were assessed
(81 nuclei/sheet); (3) the angles between the longitudinal axis of
the cell sheet and the long axis of the nuclei were determined
with the “angular” tool of the AxioVision software v 4.8 (Carl
Zeiss, Jena, Germany); (4) 324 and 486 angles for Y- and
A-TSPC cohorts were analyzed, respectively; (5) the distribution
of nuclear angle deviation for each cell type was generated
with GraphPad Prism.
Nuclear Staining and Cell Density
Analysis
Cryosections of Y-TSPC (n = 4 donors) and A-TSPC (n = 6
donors) sheets (1 sheet/donor) were rehydrated in water
for 5 min, then stained with 4′,6-diamidino-2-phenylindole
(DAPI; 1:10 × 103 dilution in H2O) for 5 min at room
temperature (RT) and fluoroprotected with Mowiol 4-88 (Roth,
Karlsruhe, Germany). Fluorescent images were acquired at 20x
magnification with an Olympus XC10 camera on an Olympus
BX61 fluorescence microscope (Olympus, Japan). In brief, (1) 9
randomly taken DAPI images/sheet were analyzed with ImageJ
(v1.45s software National Institutes of Health, Bethesda, MD,
United States)1 software; (2) each image was converted into
grayscale by using “threshold” adjustment tool; (3) total nuclear
number and the nuclear aspect ratio (NAR) were quantified
automatically with “analyze particles” tool; (4) the average cell
(nuclei) density/sheet as well as per cell cohort was calculated
and expressed per mm; (5) the frequency of different NAR
for each cohort was generated with GraphPad Prism. Round
cells are represented by NAR value close to 1, while flattened
cells near to 0.
F-Actin Staining
Cryosections of Y-TSPC (n = 4 donors) and A-TSPC (n = 6
donors) sheets (1 sheet/donor) were rehydrated in water for
5 min and permeabilizated with 0.2% Triton-X (Sigma-Aldrich)
for 30 min at RT. Afterward, 1:200 phalloidin-AF488 in 1%BSA
in PBS solution (Sigma-Aldrich) was applied for 60 min at RT.
DAPI was used for nuclear counter-staining.
Resazurin Assay and DNA Quantification
Resazurin assay was performed on the last day of the
stimulation step according to the manufacturer’s instructions
(Sigma-Aldrich). Relative immunofluorescence was measured
with fluorescent ELISA reader (TECAN, Zurich, Switzerland).
1https://imagej.nih.gov/ij/
Y-TSPC (n = 3 donors) and A-TSPC (n = 3 donors) 2D
monolayers (3 dishes/donor) were evaluated.
Cell proliferation was estimated in 3D by DNA quantification
of Y-TSPC (n = 3 donors) and A-TSPC (n = 3 donors)
sheets (1 sheet/donor). All samples were digested with papain
for 16 h at 60◦C. Next, the DNA content was quantified
by using a PicoGreen DNA kit (Invitrogen, Carlsbad, CA,
United States) following the manufacturer’s instructions.
A standard curve based on known DNA concentration was
applied to determine the total DNA content of the samples.
Relative immunofluorescence was measured with TECAN.
TUNEL (Terminal Deoxynucleotidyl
Transferase dUTP Nick end Labeling)
Staining and Quantification
Cell apoptosis was detected by TUNEL staining of Y-TSPC (n = 4
donors) and A-TSPC (n = 6 donors) sheets (one sheet/donor).
Samples were treated with 0.2% hyaluronidase (Sigma-Aldrich)
for 1 h, and then permeabilized with 0.2% Triton-X. TUNEL
reaction was carried out at 37◦C for 1 h. Afterward, DAPI
counterstaining (1:10× 103 dilution in H2O) was applied and the
samples were mounted for imaging. 10 µl DNase in 70 µl RNA
free buffer (Qiagen, Hilden, Germany) was applied. DNA-treated
samples were used as a positive control. Apoptotic cell number
was measured as follow: (1) 6 images/sheet were randomly taken
at x20 magnification; (2) all images were analyzed by ImageJ
software; (3) apoptotic cells were counted manually and average
number per donor and per cohort were expressed per mm2.
RNA Isolation, cDNA Synthesis and Real
Time Polymerase Chain Reaction (PCR)
Y-TSPC (n = 3 donors) and A-TSPC (n = 3 donors) sheets (1
sheet/donor) were snap frozen ad cryocrushed, then used for total
RNA extraction with Qiagen RNeasy Mini kit (Qiagen) following
the manufacturer’s instructions. For cDNA synthesis, 0.5 µg
total RNA/sample and Transcriptor First-Strand cDNA Synthesis
Kit (Roche, Mannheim, Germany) were used. Custom-designed
Real-Time PCR plates with 48 different genes (Table 1) in format
of 96-well/32+ by Bio-Rad (Bio-Rad Laboratories, Hercules, CA,
United States) were implemented according to the manufacturer’s
instructions and our previously described protocols (Yin et al.,
2019). Gene expression differences were calculated with the
11CT method and presented as fold change of A-TSPC
group to Y-TSPC group (control). Hypoxanthine-guanine
phosphoribosyltransferase 1 gene (HPRT1), low abundant but
also very stable, was implemented as housekeeper in calculating
1CT. The CT values of HPRT1 were also used as indicative
of gene abundance. The average CT value of HPRT1 was 27
(n = 6). From the 48 target genes, 38 genes had CT values
lower than HPRT1. Threshold of HPRT1 Ct (27) + 3 Ct ≥ 30
Ct was set and genes with Ct ≥ 30 were considered not
detectable or very low abundant, and therefore without fold
change calculation. For cell senescence analysis, Real Time
PCR for p16, p21, and p53 genes (Table 2) was performed as
described by Kohler et al. (2013).
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TABLE 1 | Genes included in Real Time PCR Ready Custom Designed Plates
analyzed in this study.
Target gene Abbreviation Category
Early growth response 1 EGR-1 Tendon transcription factor
Early growth response 2 EGR-2 Tendon transcription factor
Eyes absent homolog 1 EYA1 Tendon transcription factor
Eyes absent homolog 2 EYA2 Tendon transcription factor
Mohawk homeobox MKX Tendon transcription factor
Scleraxis homolog A SCXA Tendon transcription factor
SIX homeobox1 SIX1 Tendon transcription factor
SIX homeobox2 SIX2 Tendon transcription factor
Collagen, type I, alpha 1 COL1A1 Collagen gene
Collagen, type III, alpha 1 COL3A1 Collagen gene
Collagen, type V, alpha 1 COL5A1 Collagen gene
Collagen, type VI, alpha 1 COL6A1 Collagen gene
Collagen, type XII, alpha 1 COL12A1 Collagen gene
Collagen, type XIV, alpha 1 COL14A1 Collagen gene
Collagen, type XV, alpha 1 COL15A1 Collagen gene
Asporin ASPN Collagen cross-linker gene
Lysyl oxidase LOX Collagen cross-linker gene
Procollagen-Lysine,2-
Oxoglutarate
5-Dioxygenase 1
PLOD1, LH1 Collagen cross-linker gene
Biglycan BGN Tendon-related matrix gene
Decorin DCN Tendon-related matrix gene
Ephrin type-A receptor 4 EPHA4 Tendon-related matrix gene
Fibromodulin FMOD Tendon-related matrix gene
Fibronectin 1 FN1 Tendon-related matrix gene
Lumican LUM Tendon-related matrix gene
Proteoglycan 4 PRG4 Tendon-related matrix gene
Tenascin C TNC Tendon-related matrix gene
Thrombospondin 2 THBS2 Tendon-related matrix gene
Thrombospondin 4 THBS4 Tendon-related matrix gene
Tenomodulin TNMD Tendon-related matrix gene
Aggrecan ACAN Other lineage gene
Collagen, type II, alpha 1 COL2A1 Other lineage gene
Alpha-actin-2 ACTA2,α-SMA Other lineage gene
Cartilage oligomeric matrix
protein
COMP Other lineage gene
Desmin DES Other lineage gene
Integrin-binding sialoprotein IBSP Other lineage gene
Fucosyltransferase 4 FUT4 Other lineage gene
Lipoprotein lipase LPL Other lineage gene
Myogenic differentiation 1 MYOD1 Other lineage gene
Myogenin MYOG Other lineage gene
Nanog homebox pseudogene 8 NANOG Other lineage gene
Octamer-binding transcription
factor 4
Oct4, Pou5f1 Other lineage gene
Peroxisome
proliferator-activated receptor
gamma
PPARG Other lineage gene
Runt-related transcription
factor 2
RUNX2 Other lineage gene
Transcription factor Sp7 SP7, Osterix Other lineage gene
SRY (sex-determining region
Y)-box 9
SOX9 Other lineage gene
Transcription factor AP-2 alpha TFAP2A Other lineage gene
(Continued)
TABLE 1 | Continued
Target gene Abbreviation Category
Transforming growth factor beta 1 TGF-β1 Other lineage gene
Transglutaminase 2 TGM2 Other lineage gene
Beta-2-Microglobulin B2M Reference gene
Glyceraldehyde 3-phosphate
dehydrogenase
GAPDH Reference gene
Hypoxanthine-guanine
phosphoribosyltransferase 1
HPRT1 Reference gene
TABLE 2 | PCR for senescence-related genes p16, p21, p53.
Target
gene
Primers Annealing
temperature
[◦C]
Cycle
number
References
p16 F 5′-caacgcaccgaatagttacg-3′ 57 35 Le
Frere-Belda
et al., 2004
R 5′-agcaccaccagcgtgtc-3′
p21 F 5′-gaacttcgactttgtcaccgag-3′ 60 30 Alcantara
et al., 2001
R 5′-cgttttcgaccctgagagtctc-3′
p53 F 5′-aaggaaatttgcgtgtggag-3′ 58 35 Gan et al.,
2005
R 5′-ttctgacgcacacctattgc-3′
Collagen I Immunofluorescent Staining
and Enzyme-Linked Immunosorbent
Assay (ELISA)
Cryosections of Y-TSPC (n = 4 donors) and 6 A-TSPC (n = 6
donors) sheets (1 sheet/donor) were treated for antigen retrieval
with 1% pepsin for 15 min at RT blocked by 1% bovine serum
albumin (BSA) for 1 h, and incubated with primary anti-
collagen type I antibody (Sigma-Aldrich, Cat. Nr. C2456, 1:200
dilution) overnight at 4◦C. Next day, anti-mouse FITC secondary
antibody (Sigma-Aldrich) was applied for 1h at RT, and last DAPI
counterstaining was done for 5 min. Fluorescent images were
acquired with an Olympus XC10 camera on an Olympus BX61
fluorescence microscope. The amount of deposited collagen I
protein was detected by ELISA. 3 Y-TSPC and 5 A-TSPC donors
analyzed (1 sheet/donor). First, total protein was extracted with
10 µg/ml pepsin and 1 mg/mL elastase. Next, collagen I Elisa kit
(Chondrex, Redmond, WA, United States) was used according to
the manufacturer’s instruction. The data was expressed as total
collagen I content/DNA.
Transmission Electron Microscopy (TEM)
Transmission electron microscopy was applied to detect the
ultrastructure of Y-TSPC (n = 3 donors) and A-TSPC (n = 5
donors) cell sheets. One cell sheet per donor was prepared
for TEM analyses. After rinsing with PBS, samples were fixed
with Karnovsky-fixatives (0.1M cacodylate-buffer with 2.5%
glutaraldehyde and 2% paraformaldehyde), then enclosed within
4% low melting agarose, post-fixed with 1% osmium tetroxide
at pH 7.3, dehydrated in graded ethanol, embedded in EMbed-
812 epoxy resin (Science Services, Munich, Germany) and finally
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polymerized for 48 h at 60◦C into an EPON block. Each
cell sheet was halved and embedded for longitudinal or cross-
sectional cutting. Semithin sections from 0.75 µm thickness
were cut and stained with toluidine blue and basic fuchsine.
After selection of appropriate areas of interest, the EPON block
was trimmed and ultrathin sections (80 nm thickness) were
cut on Reichert Ultracut-S ultramicrotome (Leica, Bensheim,
Germany). Sections were mounted on grids and stained with
aqueous 2% uranyl acetate and lead citrate solution for 10 min
each. Next, the sections were examined with a LEO912AB
electron microscope (Zeiss, Oberkochen, Germany) operating at
100 kV. Images were taken with a side-mounted 2k x 2k-CCD-
camera (TRS, Moorenweis, Germany). The number of elongated
cells and apoptotic cells (images of 80 × 80 µm2), as well as
the diameter of the collagen fibers (images of 4 × 4 µm2) were
evaluated as follows: (1) 6 images/donor were implemented;
(2) all images were analyzed by ImageJ; (3) each image was
converted to grayscale by using “threshold” adjustment; (4) the
number of elongated cells, apoptotic cells and collagen fibrils
were counted manually and the data was expressed as the mean
of counted objects per image area per donor; (5) the diameter of
collagen fibrils was measured by “straight” tool manually as 20
randomly chosen fibrils per image were assessed (6 images/donor;
120 fibrils/donor; 360 fibrils for Y-TSPC group and 600 fibrils
for A-TSPC group were analyzed); (6) the collagen diameter
distribution per group was expressed by calculating the frequency
of fibrils with different diameters (total of 360 fibrils for Y-TSPC
group and total of 600 fibrils for A-TSPC group). In Figures 4, 5
representative images of Y-TSPC (n = 3 donors) and A-TSCP
n = 5 (donors) are shown. GraphPad Prism v.5 software was used
for quantitative data analyses and graphical data expression.
Statistics
GraphPad Prism v.5 software was used for expressing
quantitative data and estimation of statistical significance.
Unless distribution and frequency data, all data shows individual
donors (dot plot) and mean values and standard deviations for
each cohort. Statistical testing was performed with unpaired
t-test. Difference were considered statistically significant when
∗p< 0.05, ∗∗p< 0.01, and ∗∗∗p< 0.001.
RESULTS
A-TSPC Showed Inferior Sheets
Formation With Higher Failure Rate
In the first expansion step, A-TSPCs needed 2 more days to
reach full cell confluence than Y-TSPCs. In the stimulation step,
Y-TSPCs took 14 days to form a cell sheet, whilst A-TSPCs
required 16.5 days (Figure 1A). The gross appearances of sheets
from both cell types were evaluated and compared (Figure 1B),
showing that A-TSPC sheets were much thinner and smaller
than Y-TSPC sheets. Then, as mentioned in the Materials and
Methods, 4 Y-TSPC donors and 9 A-TSPC donors were used
in the study, and the total success rate for Y-TSPC sheet
formation was 96.5% with only 1 failed sheet from Y3-TSPC
donor (ruptured) because of the over stretching when handled.
In contrast, for the A-TSPC group the overall success rate of
sheet formation was only 61.1% and certain donors namely A1-,
A3-, and A5-TSPC being unable to form any sheet (Figure 1C).
Next, cell sheet diameter and wet weight at day 1 and 14
were measured confirming that A-TSPC sheets were significantly
smaller and lighter than Y-TSPC sheets at both the time
points (Figures 1D,E).
A-TSPC Sheets Had Lower Cell Density,
Disorganized Matrix and Poor Cell
Alignment
The general tissue morphology of the cell sheets was revealed by
H&E staining (Figure 2A) and analysis of the angle of nuclear
deviation (Figure 2B). A-TSPC cells formed an inferior cell
sheet with less matrix deposition and frequent gaps. Y-TSPC
formed bigger cell sheet containing a large amount of aligned
fibrous matrix with higher number of spindle-like shaped cells. In
addition, the cells in the A-TSPC sheets were sparser and rounded
compared to the Y-TSPC group. Cell orientation was assessed by
estimating the angular deviation of the cell nuclei to the axial axis
of the cell sheet. The results showed that in the Y-TSPC group,
over 60% of the nuclei deviated 0◦ to 20◦ from the axial axis, and
the average nuclear angle was 15.69◦. In contrast, in the A-TSPC
group, less than 30% of the nuclei deviated from 0◦ to 20◦,
and the average nuclear deviation was nearly twofold increased
to 29.95◦. Next, the cell density and frequency distribution of
the nuclei aspect ratio, which represents the nuclei flattening,
were quantified (Figures 2C–E) and revealed a significantly
lower cell density in the aged group. Moreover, A-TSPC sheets
contained significantly higher frequency of cells with NAR
0.8-0.9 corresponding to roundish cells. Analyses of the cell
cytoskeleton via phalloidin fluorescent staining confirmed worse
cell elongation and cytoskeletal organization in the A-TSPC
group than the Y-TSPC group (Figure 2F).
A-TSPC Sheets Showed Reduced
Metabolic and Proliferative Activities,
Whilst Augmented Apoptosis,
Senescence
For cell proliferation, Resazurin assay was carried out at the
2D cell monolayer level prior to sheet formation (day 18.5 for
Y-TSPCs and day 22.5 for A-TSPC), followed by DNA content
quantification. DNA was also quantified at the 3D cell sheet level
at day 1 and day 14 (Figures 3A–C). The results showed that
A-TSPC group contained significantly lower cell amount than
Y-TSPC group, paralleled by significantly higher metabolic cell
activity, in the 2D step. At the 3D level, the data suggested that
after the collection of the cell sheets in the A-TSPC group there
is further cell loss. In contrast, in the period day 1 to day 14 at
the 3D level cell proliferation occurred in the Y-TSPC sheets as
indicated by an increase in DNA content. Furthermore, TUNEL
staining of Y-TSPC and A-TSPC cell sheets revealed that A-TSPC
sheets have significantly more apoptotic cells than Y-TSPC sheets
(Figures 3D,E). Cell senescence analysis was performed by
quantitative PCR for the expression of cell cycle regulator genes
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FIGURE 2 | Y-TSPC and A-TSPC histomorphometrical analyses. (A) Representative H&E images of Y-TSPC and A-TSPC sheets at day 14. (B) Frequency
distribution of nuclear angle deviation (left panel) as well as maximum and average values of angular deviation (right panel, virtual angle between cell sheet
longitudinal axis and nuclear axis). The arrow indicates the higher frequency of nuclear deviation of 10◦–20◦ deviation in the Y-TSPC sheets. (C) Representative
images of nuclear staining via DAPI (blue color) of Y-TPSC and A-TPSC sheets. (D) Average cell density of both groups. (E) Frequency distribution of NAR (nuclear
aspect ratio, nucleus width versus length). The arrow indicates the higher tendency of NAR 0.8-1 (round cells) in A-TSPC group. (F) Representative F-actin images of
Y-TSPC and A-TSPC sheets at day 14. Y-TSPC n = 4; A-TSPC n = 6; *p < 0.05*.
p16, p21, and p53 and it demonstrated a significant upregulation
of p16 and p21 in the A-TSPC sheet group (Figure 3F).
A-TSPC Sheets Exhibited a Profound
Phenotype at the Ultrastructural Level
The ultrastructure of Y-TSPC and A-TSPC sheets was revealed
by TEM. In Y-TSPC sheets, cells appeared elongated and in
many locations organized in parallel rows compared to A-TSPC
sheets (Figures 4a–l). In addition, Y-TSPC sheets had higher
cellular density (Figures 4a–c); the ECM was rich in collagen
type I fibrils that were densely packed (Figures 5a–c). In contrast,
A-TSPCs exhibited a rounded morphology within the sheets as
well as their ECM was less dense and contained few sparsely
distributed collagen fibrils (Figures 4g–l, 5g–i). In the Y-TSPC
sheets, plasmalemma vesicles at the cell membrane (Figure 5d)
as well as cell protrusions (Figures 4d–f) and cell-cell contacts
(Figure 5e) were frequently detected. They were also visible in
A-TSPC sheets but very rarely (Figures 4j–l, 5j,k). Interestingly,
A-TSPC sheets contained multiple apoptotic bodies indicative
of cells that undergo programmed cell death (Figures 4g–i, 5l).
Apoptotic cells were rare in sheets formed by Y-TSPCs
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FIGURE 3 | Quantitative analyses of cell proliferation, apoptosis and senescence. (A,B) Resazurin assay and DNA quantification at 2D prior sheet collection.
(C) DNA quantification at 3D day 1 and day 14. (D) Representative TUNEL/DAPI images at 3D day 14. Apoptotic cells appear in green. Positive control with DNase
treated. Negative control with label solution only (without terminal transferase). (E) Quantification of average apoptotic cell number in the sheets at day 14.
(F) Quantitative PCR analysis of p16, p21, and p53. Y-TSPC n = 4; A-TSPC n = 6; *p < 0.05 and ***p < 0.001. For PCR, Y-TSPC n = 3; A-TSPC n = 3.
(Figures 4a–c, 5f). However, both types of cells however were
comparable regarding vacuoles and mitochondria (Figures 4d–
f,j–l, 5d,e,j,k). Next, quantification analysis of TEM image
data confirmed the above observation and clearly showed that
A-TSPC sheets had a significantly reduced number of elongated
cells and collagen fibrils, but significantly increased number
of apoptotic cells (Figures 6A,B,D). Regarding collagen fibril
diameter distribution, both types of cell sheet were comparable
with fibril diameter spanning 10–50 nm (Figure 6C). In all, the
TEM analyses strongly confirmed the profound phenotype of the
A-TSPC sheet at the ultrastructural level.
A-TSPC Sheets Contained Lower
Collagen I Protein
In addition, to the TEM analysis, collagen type one
deposition was further validated by conducting collagen I
immunofluorescence staining and ELISA (Figures 7A,B). Our
results clearly demonstrated that A-TSPC sheets had significantly
lower collagen I protein content than Y-TSPC sheets.
A-TSPC Sheets Displayed Abnormal
Gene Expression Profile
Real-time PCR for 48 different genes (Table 1) was carried out
with mRNA/cDNA collected from Y-TSPC and A-TSPC sheets at
day 14. Gene markers for other lineages, namely for cartilage -
collagen 2a1 (COL2A1) (cartilage); for muscle – desmin (DES),
myogenic differentiation 1 (MYOD1) and myogenin (MYOG);
for bone – Sp7 (SP7, Osterix) and integrin-binding sialoprotein
(IBSP); for fat – AP-2 alpha (TFAP2A) and lipoprotein lipase
(LPL); and for embryonic lineage – Nanog homebox pseudogene
8 (NANOG) were not detectable. Several genes that are
tendon-related – early growth response protein 2 (EGR2), eyes
absent homolog 1 (EYA1), transglutaminase 2 (TGM2) and
tenomodulin (TNMD) were also not detectable or very low
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FIGURE 4 | Representative transmission electron microscopy (TEM) images of Y-TSPC and A-TSPC sheets. (a–c) Y-TSPC sheet cell arrangement, cell density and
morphology. (d–f) Close view of Y-TSPC morphology and cell protrusions. (g–i) A-TSPC sheet cell arrangement, cell density and morphology. (j–l) Close view of
A-TSPC morphology and cell protrusions. Black arrows, apoptotic cells; green arrows, cell protrusions; red arrows, cell–cell contact; m, mitochondria; n, nucleus; v,
vacuoles; *, longitudinal cell; Y-TSPC n = 3, A-TSPC n = 5 were investigated.
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FIGURE 5 | Representative transmission electron microscopy (TEM) images of Y-TSPC and A-TSPC sheets. (a–c) Y-TSPC sheet collagen fibrils. (d) Y-TSPC sheet
plasmalemma vesicles at the cell membrane. (e) Y-TSPC sheet cell-to-cell contacts between cells. (f) Y-TSPC sheet close view of apoptotic bodies. (g–i) A-TSPC
sheet collagen fibrils. (j) A-TSPC sheet plasmalemma vesicles at the cell membrane. (k) A-TSPC sheet cell-to-cell contacts between cells. (l) A-TSPC sheet close
view of apoptotic bodies. Arrow head, collagen fibrils; black arrows, apoptotic cells, brown arrows, plasmalemma vesicles; red arrows, cell–cell contact; m,
mitochondria; n, nucleus; v, vacuoles; Y-TSPC n = 3, A-TSPC n = 5 were investigated.
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FIGURE 6 | Quantification of elongated cells (A), collagen fibrils and diameter distribution (B,C) and apoptotic cell numbers (D) from TEM images. Y-TSPC n = 3;
A-TSPC n = 5; for (A,B,D), 6 images/donor were analyzed; for (C) 20 randomly chosen fibrils per image were assessed; *p < 0.05.
abundant. The mRNA levels of tendon transcription factors
(Figure 7C) were comparable between the two groups. Several
collagen genes namely collagen 1a1 (COL1A1), collagen 3a1
(COL3A1), collagen 5a1 (COL5A1), collagen 6a1 (COL6A1),
collagen 15a1 (COL15A1), had significantly lower expression in
the A-TSPC sheets (Figure 7D). In addition, a gene related to
collagen cross-linking such as procollagen-lysine, 2-oxoglutarate
5-dioxygenase 1 (PLOD1) and the matrix proteoglycans decorin
(DCN), fibromodulin (FMOD), fibronection (FN), tenascin
C (TNC) and thrombospondin 2 were also significantly
downregulated in the A-TSPC sheets (Figures 7E,F). Regarding
other lineage related genes, three genes aggrecan (ACAN),
alpha-actin 2 (ACTA2), cartilage oligomeric matrix protein
(COMP) were also found to be expressed to a lower extent in the
A-TSPC group (Figure 7G). Altogether, this data demonstrated a
fundamental matrix synthesis problem in the A-TSPC sheets.
DISCUSSION
Tendon injuries, which associate closely with aged-related
tissue degeneration present great challenges to orthopedic and
trauma surgery departments. Aged-related tissue degeneration
has been previously linked to impaired functions of tissue-
resident stem/progenitor cells (Smith et al., 2002; Rees et al.,
2006; Asai et al., 2014). Han et al. suggested that with donor
aging smooth muscle-derived MSCs have greatly diminished self-
renewal and proliferation abilities but augmented senescence
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FIGURE 7 | Collagen I protein production and gene expression profiling by Real Time PCR. (A) Representative collagen I immunofluorescent images of Y-TSPC and
A-TSPC sheets at day 14. (B) Quantitative analysis of collagen I by ELISA. For (A,B) Y-TSPC n = 3; A-TSPC n = 6. Normalization to DNA. Quantitative PCR analysis
for tendon-transcription factors (C), collagen genes (D), cross-linker genes (E), tendon-related ECM genes (F) other lineage genes (G). Gene expression was
calculated as fold change to Y-TSPC group. GAPDH was used as reference gene in each group. Non-detectable (Ct over 38 genes were not included in the graphs.
For (C–G) Y-TSPC n = 3; A-TSPC n = 3; ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001.
(Han et al., 2010). In order to investigate how aging affects
TSPCs, we compared the phenotypic difference between Achilles
tendon-derived Y-TSPC from young/healthy and A-TSPC from
aged/degenerative human donors. Our previous data in 2D
culture, revealed that A-TSPC had a significantly reduced cell
adhesion, migration and self-renewal abilities with distinct
clonogenic deficits and premature entry into senescence (Kohler
et al., 2013), suggesting that the TSPC pool is becoming exhausted
in terms of size and functional fitness during tendon age-
related degeneration.
Here, we applied a previously established cell sheet model
(Hsieh et al., 2018) for in vitro tenogenesis and compared the
sheet formation of Y-TSPCs and A-TSPCs with the purpose
of unraveling differences in their potential to form 3D tendon
organoids. Formation of cell sheets is an alternative scaffold-
free approach to build an abundant ECM niche without
elimination of the native connections between cells to cells
and cells to ECM. Furthermore, the cell multilayer contains
a natural microenvironment and maintains its own autocrine
and paracrine signaling (Hsieh et al., 2018). Several growth
factors such as members of the Transforming Growth Factor
beta family, TGF-β1, β2, and β3, have been reported to be
critical for tendon tissue formation, function and healing (Pryce
et al., 2009; Maeda et al., 2011; Havis et al., 2014; Tan et al.,
2020). Connective Tissue Growth Factor (CTGF) has also been
linked to tenogenesis; for example, it is pro-tenogenic factor
of adipose-derived stem cells (Shen et al., 2018; Li et al.,
2019). Interestingly, Yin et al. (2016) have combined CTGF
and TGF-β1 in a step-wise manner, which led to augmented
tenogenic differentiation of MSCs, as well as to tendon-like
tissue formation in the repair process of rat patella tendon
defect. CTGF alone or in combination with TGF-β has also
been associated with fibrocartilage formation in meniscal injury
models (Lee et al., 2014; Tarafder et al., 2019). Therefore, as well
as to minimize costs, we designed our study with administration
of only one growth factor from the TGFβ family. However, it
will be of great importance in follow up research to investigate
the synergistic action of CTGF and TGFβ in the 3D tendon
cell sheet model, which may result in quicker maturation of
the cell sheets.
In the present study, our results clearly showed that A-TSPCs
exhibit profound deficits in forming 3D tendon tissue organoids.
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There are several possible explanations: A-TSPC sheets have
(1) reduced cell proliferation; (2) augmented cell apoptosis and
senescence; and (3) less ECM production.
Tissue and organ aging has a strong relationship with
stem cell proliferation ability, apoptosis and senescence. Kasper
et al. (2009) reported that the size of MSCs pool reduces in
aged animals, compared to young animals. Yu et al. (2011)
demonstrated that aged rhesus macaque BMSCs require longer
population doubling time due to decreased proliferation capacity.
In our study, cell proliferation was tested prior to sheet
collection and at day 1 and 14, revealing that A-TSPC sheets
have significantly lower cell density and proliferation rate than
Y-TSPC sheets. Kawakami et al. (2019) communicated that
progeroid mice contained higher numbers of apoptotic muscle
stem/progenitor cells. Taylor et al. (2003) showed that in human
colonic crypts, age-related DNA mutations are associated with
stem cell apoptosis. By performing TUNEL assays for DNA
damage, we observed that the A-TSPC sheets also contain
more apoptotic cells than the Y-TSPC group. Furthermore,
we found that senescence-related gene markers namely p16
and p21 (Campisi, 2005) were significantly upregulated in the
A-TSPC group, This finding is in line with skeletal muscle
aging, where local stem cells undergo a dysregulation in p16
signaling that is directly related to an augmentation in muscle
tissue senescence. Interestingly, reducing p16 expression might
be a way to postpone tissue and organ aging (Baker et al.,
2011). Silencing of p16 expression can reduce the number of
senescent cells thus restoring the regenerative potential of muscle
tissue, which was shown by Sousa-Victor et al. (2014). In all,
the above results indicated that A-TSPC 3D sheets, characterized
with a lower cell density and proliferation potential, whilst having
higher cell apoptosis and senescence, are significantly inferior
then Y-TSPC sheets.
Tendon ECM is very fibrous and organized in parallel
collagen fibers. Roughly 95% of the collagen is type I, with
small levels of collagen types III, V, VI, XII, XIV, and XV.
The non-collageneous proteins in the tendon ECM belong to
proteoglycan and glycoprotein family and smaller amount of
proteoglycans (e.g., decorin, biglycan, fibromodulin, lumican)
such glycoproteins (e.g., COMP, TNC, PRG4. TNMD) (Docheva
et al., 2015; Screen et al., 2015). In the current study, we could
not detect TNMD gene expression in neither of the TSPC
groups, most likely due to transcript loss in the cell expansion
step. Rapid downregulation of TNMD mRNA in 2D and 3D
cultured human TSPCs was previously described (Dex et al.,
2017). The ECM provides a natural physical microenvironment
for cellular connections and also regulates cellular processes such
as proliferation and differentiation (Theocharis et al., 2016). Aged
stem cells still possess multipotency and are capable of ECM
deposition (Stolzing and Scutt, 2006; Yu et al., 2011). However,
it has been reported that cell aging can lead to a reduction
in COL content (Haut et al., 1992; Couppe et al., 2009). In
our study, we found that A-TSPC sheets contained significantly
less ECM with poor alignment when compared to the Y-TSPC
sheets. Connor et al. (2019) showed that senescent fibroblast has
downregulated COL1A1 and elastin gene expression, compared
to young fibroblast. This is comparable to our study revealing in
A-TSPC sheets had a significant lower COL1 expression at mRNA
and protein levels. COL 3 and COL 5, fibrillar collagens expressed
in the human tendon tissue, that are important for the optimal
fibrillary formation and tissue quality (Kannus, 2000) were both
also significantly downregulated in the A-TSPC group. Our
results are in line with two omics studies. Proteomic analysis of
engineered tendon constructs by young or aged equine tenocytes
revealed that tendon aging was associated with altered ECM
protein, and especially COL type I, III and IV as well as proteins
involved in cell-matrix interaction and mechanotransduction
such as calponin 1, paladin, caldesmon 1 and contracting (Turlo
et al., 2018). Moreover, the data suggested a lower cytoskeleton
turnover in the aged group (Turlo et al., 2018), confirming
independently the findings in Kohler et al. (2013). Transcriptome
comparison of uninjured human Achilles tendon tissue biopsies
from young and old patients demonstrated with tendon age
a differential expression of genes related to cellular function,
growth and the cell cycle (Peffers et al., 2015). Interestingly,
downregulation of COL transcripts and genes involved in the
post translational modification of COL were also affected (Peffers
et al., 2015). A gene called SPARC (secreted protein acidic and
rich in cysteine) has been shown to play an important role in
ECM assembly and particularly in dermal fibroblast to regulate
processing of procollagen I and COL fibrilogenesis (Rentz et al.,
2007; Bradshaw, 2009). Interestingly, tendon tissues from Sparc-
deficient mice, also exhibited altered actin cytoskeleton as well as
collagen fibrilogenesis defects (Gehwolf et al., 2016) and hence,
will be relevant to assess in the future, SPARC expression levels in
the A-TSPC sheets. On the contrary, the study by Couppe et al.
(2014) suggested that the COL fibril numbers remain unchanged
during aging in both animal and human tendon tissue, but the
enzymatic or non-enzymatic cross-linkers of the fibrils, thereby
their size, can be affected during aging (Svensson et al., 2016).
We analyzed other genes related to COL fibril regulation such as
proteoglycans (DCN, FMOD, FN1, TNC, THBS2, COMP) and
PLOD1, and found several being significantly downregulated in
the A-TSPC group. These novel molecular candidates can be the
foundation in follow up studies to investigate molecular cascades
in both directions – up and downstream in order to elucidate
the molecular mechanisms leading to the deficiency in matrix
synthesis by A-TSPCs. Altogether, this data indicates the A-TSPC
group harbors significant ECM production deficit.
With aging some structural changes of the COL fibrils occur;
as mentioned above, changes in their size, but also shape and
even biomechanical properties (Rahmati et al., 2017). We carried
out TEM and investigated COL fibril diameter size but found
no significant differences between the groups. One possibility is
that during in vitro culture without dynamic mechanical loading
the lateral growth of the COL fibril size is limited. In future, it
will be of interest to subject both type of sheets to periodic axial
stretching, as well as to examine their biomechanical properties,
for example by the means of Force Indentation Atomic Force
Microscopy. Nevertheless, the TEM analyses independently
validated that A-TSPC contained less and disorganized cells
exhibiting round and apoptotic morphologies embedded in a very
poor COL matrix. The structural and biomechanical properties
of the ECM can profoundly affect cell behavior. Interestingly,
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providing A-TSPCs with hydrogel environment consisting of
aligned nanonfibers alleviated their aged phenotype (Yin et al.,
2020). Hence, “engineering a healthy” ECM niche might be an
attractive way to rejuvenate aged cells, support their growth and
direct their fate decision and differentiation.
Our study has several shortcomings that need to be addressed
in follow up research: (1) Due to the manual rolling of the cell
sheets, some ECM and cells are lost, therefore standardizing
this process will be of importance; (2) A time point longer
that 14 days can be evaluated to investigate if the A-TSPC
sheets further deteriorate; (3) As mentioned above, subjecting
the 3D tendon organoids to periodic axial stretching will be
relevant to examine if this can lead to sheet diameter growth.
In addition, efforts to speed up the sheet formation process and
to become more economic, regarding required cell numbers will
be very important.
Taken together, our study reports as in 2D culture, so in
3D culture A-TSPCs show cell autonomous deficits namely,
significantly reduced renewability but significantly increased
senescence and apoptosis. Furthermore, we report the following
novel findings: (1) A-TSPCs have a severe issue with ECM
production, which was validated at the mRNA and protein levels;
(2) they are less competent to organize the ECM and to properly
align in the third dimension; (3) Q-PCR profiling identified
novel molecular candidates such as collagen genes (COL I,
III, V, VI, and XV) and proteoglycans (DCN, FMOD, FN1,
TNC, THBS2, COMP, PLOD1) which can help to elucidate the
exact molecular circuits behind the deficiency in ECM synthesis.
Further validation at the protein level as well as “gain” and “loss”
of function experiments will be of great interest to follow. Last
but not least, the 3D sheet model can become very attractive
for (1) developing an effective 3D tenogenic differentiation
protocol for wide use similarly to the well-known and accepted
chondorgenic in pellet cultures and (2) for screening of small
pharmacological cues for rejuvenation of the A-TSPC sheets and
to evaluate side effects of available or in development medications
on tendon tissues.
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